Moreover, consistent with its activity promoting osteoclastogenesis and bone resorptive activity, the knock-down of Sema4D in HNSCC cells reduced bone invasion in preclinical mouse models. This evidence concerns the gene SEMA4D and head and neck squamous cell carcinoma.